TRAINING AND RESEARCH PROJECTS WITH PUBLICATION@ARAVINDABIO

[Aravinda Bio]

WE ARE PROVIDING BIOINFORMATICS TRAINING AND PROJECTS SINCE YEAR 2000.

 

AravindaBio invites applications for Industrial Training, Research/Academic Projects with Publication support and Guidance on BIOINFORMATICS, CHEMINFORMATICS, Molecular Modelling& Drug Designing (MMDD), Computer Aided Drug Designing (CADD), Fragment Based Drug Designing (FBDD), Docking Studies, 2D QSAR, 3D QSAR, HOMOLOGY MODELING, PERL, BIOPERL Programming, in the Months of OCT, NOV, DEC-2013.

 

Interested candidates can register their names by email or phone call. Limited students in each batch. For more details just fill the enquiry form available in our website. Email: manoj...@aravindabio.com, enq...@aravindabio.com, aravi...@yahoo.com or call 09391187818 (Raghu Raj).

 

For more details Please visit our website: http://www.aravindabio.com.

 

 

AravindaBiosolutionsPvt. Ltd.,

#311, Windsor Plaza,

Shankermutt, Nallakunta,

Hyderabad, Pin: 500 029

Andhra Pradesh, India.

Ph: 040-66628773

Mobile: 09391187818 (RAGHU RAJ)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

PUBLICATION DETAILS OF OUR STUDENTS AND FACULTIES:

 

 

1. MOLECULAR MODELING, DOCKING AND ADMET STUDIES TOWARDS DEVELOPMENT OF NOVEL DISOPYRAMIDE ANALOGS FOR POTENTIAL INHIBITION OF HUMAN VOLTAGE GATED SODIUM CHANNEL PROTEINS.KhunzaMeraj, Manoj Kumar Mahto, N Blessy Christina, Nidhi Desai, SajadShahbazi, Prof. M Bhaskar. Bioinformation.2012, 8(23), 1139-1146.

 

2.      MOLECULAR DOCKING AND ADMET STUDY OF QUINOLINE-BASED DERIVATIVES FOR ANTI-CANCER ACTIVITY, Manoj Kumar Mahto, KhunzaMeraj, Eftekhari K, Zeinab MN, Poojitha G, Bhaskar M. Vedic Research International Bioinformatics & Proteomics. 2013, 1(1), 1-8.

 

3. ADMET & MOLECULAR DOCKING STUDIES OF NOVEL ZANAMIVIR ANALOGS AS NEURAMINIDASE INHIBITORS.Manoj Kumar Mahto, V Likhitha Raj, Prof. M. Bhaskar, Divya.R. International Journal of Pharmaceutical Sciences Review and Research. 2012, 13(1), 91-94.

 

4. DEVELOPMENT OF BETTER ANALOGS OF VALPROIC ACID FOR THE TREATMENT OF EPILEPSY BY CADD.Manoj Kumar Mahto, Jaya Tripathi,Divya. R, Prof. M. Bhaskar.International Journal of Pharmaceutical Sciences and Drug Research.2012, 4(1), 77-79.

 

5. INSILICO DESIGN AND DISCOVERY OF SOME NOVEL ACHE INHIBITORS FOR TREATMENT OF ALZHEIMER’S DISORDER.Sandeep Reddy Ch, Sree Kumar Reddy G, Manoj Kumar Mahto, PavanKunala, ChaitanyaKanth R.Research Journal of Pharmacy and Technology. 2012, 5(3), 425-428.

 

6. MOLECULAR DOCKING AND TOXICITY ANALYSIS OF NOVEL ATORVASTATIN STRUCTURAL ANALOGUES WITH HMG-COA REDUCTASE, Jaya Tripathi, Manoj Kumar Mahto, Divya. R, Prof. M. Bhaskar, SajadShahbazi. Asian Journal of Research in Chemistry. 2012, 5(3), 386-389.

 

7. COMPARATIVE DOCKING STUDIES OF ESTROGEN RECEPTOR INHIBITORS AND THEIR BINDING INTERACTION ANALYSIS,Nidhi Desai, Manoj Kumar Mahto, B.Alekhya, C.R.Naveen, Prof. M.Bhaskar. International Journal of Pharmaceutical Sciences Review and Research. 2012, 16(1), 91-95.

 

8. DOCKING ANALYSIS, ADME AND TOXICITY PROFILES OF INDAZOLE PYRIDINE BASED PROTEIN AKT INHIBITORS,N BlessyChristina, Manoj Kumar Mahto, KhunzaMeraj, Prof. M Bhaskar. International Journal of Pharmaceutical Sciences Review and Research.2012, 17(2), 56-61.

 

9.      PHARMACOPHORE MODELLING, 3D-QSAR STUDY AND DOCKING OF NAPHTHOL DERIVATIVES AS B-RAF(V600E) RECEPTOR ANTAGONISTS, KhunzaMeraj, K. Kiran Kumar, , Mohamed Sidig, AzamSoltany, P. Anugnya Reddy, Manoj Kumar Mahto, M Bhaskar. Vedic Research International Bioinformatics & Proteomics. 2013, 1(1), 18-29.

 

10.  ANALOGS OF CARBIDOPA: INSILICO DESIGN & DEVELOPMENT OF NOVEL DOPA DECARBOXYLASE INHIBITORS IN THE TREATMENT OF PARKINSON’S DISEASE. M Lakshmi Vasavi Devi, Deepak Reddy Gade, T GopiRaju, PavanKunala. Journal of Pharmaceutical Sciences & Research. 2011, 3(4), 1176-1181.